INTERBRI · CHINA MARKET ACCESS FOR MEDICAL DEVICES China-focused support. Clear scope. Accountable coordination.

Change Your China Medical Device Agent

When your China agent is also your distributor, or your current arrangement no longer fits, changing the designated representative is both a commercial and a regulatory decision. INTERBRI helps overseas manufacturers move to independent China representation while keeping their registration dossier and in-country communication under control.

When a Change of China Agent Makes Sense

Overseas manufacturers usually revisit their China representation when the commercial and regulatory sides of the relationship have become entangled. A distributor can be an excellent sales partner, but combining distribution with the designated agent role concentrates registration dossier access, authority contact and commercial negotiation in one counterparty.

INTERBRI works as an independent China-focused partner. We support the transition from an existing arrangement to an independent agent, and then provide the ongoing local representation, communication and compliance coordination your China matters require.

  • Independence — Keep regulatory representation separate from your sales channel.
  • Continuity — Preserve dossier access, correspondence history and local contact channels.
  • Clarity — Know exactly which documents, responsibilities and contacts move, and when.
  • One team — English with your headquarters, Chinese with local counterparts.
Illustration of a structured transition between China representation arrangements
COMMON DRIVERS

Why Manufacturers Rethink a Distributor-Led Arrangement

These are the situations we most often see when overseas teams open a conversation about changing their China agent.

Registration dossier control

  • Technical documentation and submission records sit with the counterparty
  • Future changes, renewals and correspondence depend on their cooperation
  • An independent arrangement keeps the manufacturer in the lead

Commercial leverage

  • Agent and distributor roles have different incentives
  • Commercial renegotiation can put regulatory continuity at risk
  • Separating the roles reduces that dependency

Communication continuity

  • Authority and testing-institution contact is often tied to one local mailbox
  • Staff changes on the partner side can break the thread
  • A dedicated local contact keeps records and follow-up consistent

Post-market responsibilities

  • Ongoing monitoring, reporting and recall support need a reachable contact
  • The arrangement must remain workable for the full product lifecycle
  • A planned handover avoids gaps in coverage
The steps, documentation and sequence for a change of representation depend on your product classification, your current registration or filing status and your existing agreements. We assess these case by case before recommending any action.
OUR SUPPORT

Agent Transition Support by INTERBRI

A structured handover, then steady representation. Our support is organised around four workstreams.

Current arrangement review

  • Map the existing agent or distributor arrangement
  • Identify which submissions, records and contacts are affected
  • Flag dependencies that need commercial alignment

Handover planning

  • Build a documented inventory of dossiers, correspondence and local records
  • Agree a sequence and responsibilities with all involved parties
  • Keep your headquarters informed at every stage

Coordination in China

  • Liaise in Chinese with the parties and institutions involved
  • Keep communication and documentation aligned during the transition
  • Track open items until each handover step is closed

Ongoing representation

  • Act as your independent China contact after the transition
  • Support registration, filing and change matters as they arise
  • Maintain clear scope and reporting under the service agreement
All duties, boundaries and deliverables are fixed in the service agreement. We do not begin a transition until the scope and sequence have been agreed with you in writing.
PROCESS

How an Agent Change Is Planned

A calm, documented sequence — no disruption to the matters already in progress.

1

Initial Review

We learn about your products, current arrangement and open matters.

2

Mapping

We list affected dossiers, records, contacts and dependencies.

3

Agreed Sequence

Scope, responsibilities and timing are confirmed in writing.

4

Handover and Support

The transition is executed, then ongoing representation begins.

FAQ

Common Questions About Changing Your China Agent

QCan we change our China agent if a distributor currently holds the role?

In many cases this can be planned and implemented, but the starting point is always your existing commercial agreement and the current status of your registration or filing. We review both before proposing any transition steps, so that commercial discussions and regulatory continuity are handled together rather than in conflict.

QWill changing our agent affect our existing registrations?

A change of representation touches the information recorded in your submissions and the channels used for ongoing communication. We map each affected item first, then agree a sequence with you so that correspondence, documentation and post-market contacts stay consistent throughout.

QWhat should we prepare before the first discussion?

A short overview of your products and their classification, your current agent or distributor arrangement, and a list of the registration or filing matters currently in progress is usually enough to start. We will tell you which additional records are useful once we understand the situation.

QHow do we start?

Send us a short note through the contact page. We will review your current arrangement, come back with a written transition outline and scope, and only then agree on next steps.

Read more about our China Agent service

Planning a change of China agent?

Tell us about your current arrangement and where your registrations stand. We will come back with a written transition outline and a clear service proposal.